Liver Transplant Unit, Freeman Hospital, Newcastle upon Tyne, United Kingdom.
Statistics and Clinical Studies, NHS Blood and Transplant, Stoke Gifford, Bristol, United Kingdom.
Transplantation. 2019 Nov;103(11):2304-2311. doi: 10.1097/TP.0000000000002687.
In the United Kingdom, liver transplantation (LT) is undertaken in 7 supraregional centers. Until March 2018, liver grafts were offered to a center and allocated to a patient on their elective waiting list (WL) based on unit prioritization. Patients in Newcastle, Leeds, and Edinburgh with a United Kingdom Model for End-Stage Liver Disease (UKELD) score ≥62 were registered on a common WL and prioritized for deceased-donor liver allocation. This was known as the Northern Liver Alliance (NLA) "top-band scheme." Organs were shared between the 3 centers, with a "payback" scheme ensuring no patient in any center was disadvantaged. We investigated whether the NLA had improved WL survival and waiting time (WT) to transplantation.
Data for this study were obtained from the UK Transplant Registry maintained by National Health Service Blood and Transplant. This study was based on adult patients registered for first elective liver transplant between April 2013 and December 2016. Non-NLA centers were controls. The Kaplan-Meier method was used to estimate WL survival and median WT to transplant, with the log-rank test used to make comparisons; a Bonferroni correction was applied post hoc to determine pairwise differences.
WT was significantly lower at NLA centers compared with non-NLA centers for top-band patients (23 versus 99 days, P < 0.001). However, WL survival was not significantly different for top-band patients (P > 0.999) comparing NLA with non-NLA centers. WL survival for nontop-band patients was no different (P > 0.999) comparing NLA with non-NLA centers.
The NLA achieved its aim, providing earlier transplantation to patients with the greatest need. Nontop-band patients did not experience inferior survival.
在英国,肝脏移植(LT)在 7 个超区域中心进行。直到 2018 年 3 月,肝脏供体根据单位优先级提供给中心,并根据其选择性等待名单(WL)分配给患者。纽卡斯尔、利兹和爱丁堡的 UKELD 评分≥62 的患者在共同 WL 上注册,并优先进行已故供体肝脏分配。这被称为北方肝脏联盟(NLA)“顶级带方案”。器官在 3 个中心之间共享,“回报”方案确保任何中心的患者都不会处于不利地位。我们调查了 NLA 是否改善了 WL 存活率和等待移植的时间(WT)。
本研究的数据来自由国民保健制度血液与移植管理的英国移植登记处。本研究基于 2013 年 4 月至 2016 年 12 月期间首次登记进行选择性肝移植的成年患者。非 NLA 中心为对照组。使用 Kaplan-Meier 方法估计 WL 存活率和中位数 WT 到移植,使用对数秩检验进行比较;事后使用 Bonferroni 校正确定两两差异。
与非 NLA 中心相比,顶级带患者在 NLA 中心的 WT 明显更低(23 天与 99 天,P < 0.001)。然而,顶级带患者的 WL 存活率在 NLA 与非 NLA 中心之间没有显著差异(P > 0.999)。非顶级带患者的 WL 存活率在 NLA 与非 NLA 中心之间没有差异(P > 0.999)。
NLA 实现了其目标,为最有需要的患者提供了更早的移植。非顶级带患者的生存率没有受到影响。